The lead product under development is an inhaled therapy intended to treat paroxysmal atrial fibrillation
The results of the trial are anticipated to be used to back up an FDA regulatory submission for a paroxysmal atrial fibrillation
Given the risk of complications with ablation, our data support the current guidelines recommending anti-arrhythmic drugs as first-line treatment in most patients with paroxysmal atrial fibrillation
," wrote Dr.
Patients with stroke of unknown origin should have at least 21 days of MCOT monitoring to reliably detect paroxysmal atrial fibrillation
in order to reduce their risk of future stroke," Miller said.
Zipes: Amiodarone is probably the most effective drug available to treat paroxysmal atrial fibrillation
This was confirmed to be recurrent paroxysmal atrial fibrillation
His medical history was significant for chronic obstructive pulmonary disease, blindness of unknown cause, paroxysmal atrial fibrillation
, ischemic heart disease, congestive heart failure, and hepatitis B virus infection.
THERMOCOOL([R])Navigation Catheters are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation
, when used with CARTO([R]) Systems (excluding NAVISTAR([R]) RMT THERMOCOOL Catheter).
InCarda's lead product in development consists of an established drug for paroxysmal atrial fibrillation
(PAF) delivered in a novel way, via inhalation.
The company claims the device is the first therapeutic catheter approved in the United States that enables direct and real-time measurement of contact force during catheter ablation procedures for patients suffering from drug-resistant paroxysmal atrial fibrillation
(AF or AFib), sustained monomorphic ischemic ventricular tachycardia and Type I atrial flutter.
Lok NS, Lau CR Abnormal vasovagal reaction, autonomic function and heart rate variability in patients with paroxysmal atrial fibrillation
BOSTON - Ablation bested antiarrhythmic drugs at reducing the incidence of time to first recurrence of atrial arrhythmias in patients with paroxysmal atrial fibrillation
, results of a randomized, multicenter trial showed.